1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02353481|
Recruitment Status : Unknown
Verified February 2015 by Aminat J Shote, University College, London.
Recruitment status was: Active, not recruiting
First Posted : February 2, 2015
Last Update Posted : February 3, 2015
|Condition or disease||Intervention/treatment|
|Heart Failure||Other: Heart Failure Management|
There is a need for a prognostic model for 1 year survival of patients discharged alive after an unscheduled hospital admission for heart failure. This study aims to develop and validate a prognostic model that will enable management planning and facilitate the identification of therapeutic needs or targets. Also, it will assist care providers to predict or quantify patients' survival based on their baseline characteristics.
The National Heart Failure Audit (NHFA) held by National Institute for Cardiovascular Outcomes Research (NICOR) is one of the largest available national heart failure registry. It includes data from unscheduled heart failure admissions in England and Wales. In the audit, heart failure diagnosis is defined as a diagnosis that has been confirmed by imaging or brain natriuretic peptide (BNP) measurement. This study will use NHFA data to develop and validate the proposed model.
|Study Type :||Observational|
|Estimated Enrollment :||63320 participants|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||March 2015|
|Estimated Study Completion Date :||March 2015|
All patients in the audit that meets the eligibility criteria
Other: Heart Failure Management
- All-cause mortality [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02353481
|University College London|
|London, United Kingdom|